14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Mar 17, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 16, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 15, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 14, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 11, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 10, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 09, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 08, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 07, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 04, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 03, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 02, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Mar 01, 2022 $0.000001 $0.000001 $0.000001 $0.000001 500
Feb 28, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 25, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 24, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 23, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 22, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 18, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 17, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 16, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 15, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 14, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 11, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 10, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT